Nawal Ouzren

Chief Executive Officer

With 15 years of experience in operational and strategic management within the pharmaceutical industry, Mrs. Ouzren started out at Baxter, where she was Strategy and Operational Excellence Manager, Quality Operations Director and Senior Director Strategy before becoming Vice President of the BioSimilars business unit. In 2014, she became Vice President of the Global Hemophilia Franchise at Baxalta, which had been incorporated within the Shire group. In 2016, she headed up the Global Genetic Diseases Franchise at Shire, where she supervised all marketing, business and strategy aspects of this global division’s product portfolio.

nawal ouzren

Géraldine Honnet

Chief Medical Officer

Géraldine Honnet is a Medical Doctor who received her diploma from Necker Enfants-malades Hospital (Children’s hospital) in 1996 and worked during 5 years as Clinical Research Physician and Investigator for the ANRS (French Agency for the Fight against AIDS) and the clinical trials for the pharmaceutical industry. After that, Géraldine worked as a Medical Director at clinical research organization Parexel International from 2001 to 2005 and then as International Project Manager for Janssen-Cilag (Johnson & Johnson) before joining biotech company Transgene in 2007, where she was responsible for the clinical development of gene therapy products for infectious diseases. Before joining Sensorion, Géraldine worked at Généthon from 2011 to January 2020 as Chief Medical Officer, overseeing international gene therapy clinical trials in multiple rare diseases. She was responsible for the development of Généthon pipeline from pre-clinical to registration, managing Medical Affairs, Clinical Development, Clinical Operations and Regulatory Affairs departments.

 geraldine Honnet

Juergen Heitmann

Chief Business Officer

Juergen Heitmann, a biologist by training with a PhD from the University of Tübingen where he already worked in the inner ear field. Juergen started his professional career in the medical device industry at Biotronik and as a Senior Consultant at McKinsey & Co. He then spent more than 20 years in the pharmaceutical industry in various Business Development roles at Novartis, Nycomed and Takeda. More recently he advised Venture Capital and Biotech companies on Corporate Development and Strategy topics. He started working for Sensorion in 2017 first as a consultant and since September 2019 as the Chief Business Officer. 

 Julien Miara

Jonas Dyhrfjeld-Johnsen, PhD

VP Research and Translational Development

With over 15 years of international experience in central nervous system and inner ear research & development, Dr. Dyhrfjeld-Johnsen’s proficiency in pathological dysfunction and neurodegenerative cell death has proven central to the company’s direction and growth. His expertise ranges from mathematical modeling and single neuron electrophysiology to functional measurements in vivo. As the Head of Pharmacology of Sensorion, Dr. Dyhrfjeld-Johnsen is inventor on several patents for treatment of inner ear disease and integrates a broad scientific expertise with an appreciation for the unmet medical need in the daily lives of patients, driving the search for targeted innovative treatments. He holds a PhD in Neuroscience from the University of Düsseldorf and Master’s Degree in Biophysics from the University of Copenhagen, followed by work as a research fellow at the University of California-Irvine and Harvard Medical School/Massachusetts General Hospital.

jonas dyhrfjeld johnsen

Aurore Brugeaud, PhD

Operations Manager
A specialist in both operational management and innovative scientific study, Dr. Brugeaud offers a unique, valuable skillset hard to come by in the industry. She has accrued an eclectic experience at Sensorion, holding positions in areas ranging from biopharmaceutical R&D to project management. Because of her continued success in her many placements across the organization, Aurore was promoted to oversee the entirety of the R&D site operations. Dr. Brugeaud has been an integral component to the company’s development from its inception, and her rare combination of talents and competencies have helped Sensorion mature into the seminal institution it is today. Her diverse contributions have rendered her the central link between all activity and business within the company, spanning all departmental affairs and external communications. She received her PhD in Neuroscience from the University of Sciences of Montpellier, and was a post-doctoral fellow at the Eaton Peabody Laboratory at the Massachusetts Eye and Ear Infirmary/Harvard Medical School


aurore brugeaud





20191220 pipeline


Corporate presentation